Market

Biocon Biologics refinances $ 1.1 bn long-term debt through USD bonds and new syndicated facility

Read more

Gilead Sciences signs licencing agreements with six companies to manufacture, commercialise Lenacapavir

Read more

Revenues to increase by 9-11 % for Indian pharma companies in FY2025: ICRA

Read more

Venus Remedies gets marketing authorisations for oncology drugs from Morocco, Philippines

Read more

Ind-Ra forecasts weak API prices and volume growth for India in FY25

Read more

Pharma sector set for 8-10 per cent revenue growth this fiscal

Read more

Atopic Dermatitis: A hotspot for innovation and investment opportunities, says GlobalData

Read more

Radiopharmaceuticals for prostate cancer to go nuclear with $6.3 bn in sales by 2030

Read more

Neovantage Innovation Parks secures a green loan for its life sciences real estate portfolio

Read more

Migraine market to reach $16.4 billion in 7MM by 2033, forecasts GlobalData

Read more